Filing Details

Accession Number:
0001127602-13-009691
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-03-06 17:35:59
Reporting Period:
2013-03-05
Filing Date:
2013-03-06
Accepted Time:
2013-03-06 17:35:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
850693 Allergan Inc AGN Pharmaceutical Preparations (2834) 951622442
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1190632 J Stephen Ryan 2525 Dupont Drive
Irvine CA 92612
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-03-05 5,700 $60.60 10,970 No 4 M Direct
Common Stock Disposition 2013-03-05 5,700 $110.00 5,270 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Nonemployee Director Stock Option (Right to Buy) Disposition 2013-03-05 5,700 $0.00 5,700 $60.60
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2017-05-01 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 42,613 Indirect By Living Trust
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 26, 2012.
  2. Includes shares acquired under the Allergan, Inc. Dividend Reinvestment Plan.
  3. S & A Ryan Living 1994 Trust, in which the reporting person has a pecuniary interest and of which the reporting person and his spouse are each trustees.
  4. Option is fully vested and exercisable on the date of the next regular annual meeting of stockholders of Allergan, Inc. at which directors are to be elected following the date of grant.